Finance

Beta
Lists
NYMXF:OTCMKTS
Nymox Pharmaceutical Corp
$0.12
0.00%
(0.00) 1D
Jun 29, 1:52:52 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NYMXF...
Open
$0.15
High
$0.15
Low
$0.12
Mkt. cap
11.34M
Avg. vol.
61.09K
Volume
3.00K
52-wk high
$0.15
52-wk low
$0.12
Beta
-0.28
Shares outstanding
94.54M
No. of employees
3
Open
$0.15
High
$0.15
Low
$0.12
Mkt. cap
11.34M
Avg. vol.
61.09K
Volume
3.00K
52-wk high
$0.15
52-wk low
$0.12
Beta
-0.28
Shares outstanding
94.54M
No. of employees
3
News stories
From sources across the web
About Nymox Pharmaceutical Corp
CEO-
Employees3
Founded1989
Headquarters-
SectorBiotechnology
Websitenymox.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2015
Dec 2015
Sep 2024
Dec 2024
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
511.00K
624.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
142.00K
164.00K
Operating expense
-
-
653.00K
788.00K
Total operating expenses
-
-
653.00K
788.00K
Operating income
-
-
-653.00K
-788.00K
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-716.00K
-857.00K
EBT excluding unusual items
-
-
-716.00K
-857.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-716.00K
-857.00K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
2.00K
Interest expense
-
-
-63.00K
-86.00K
Net interest expenses
-
-
-63.00K
-84.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-652.67K
-788.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer